The Supreme Court's May 2009 ruling in Ashcroft v. Iqbal is quickly becoming the best thing to happen to the product liability defense bar since Daubert. We told you a couple of weeks ago about the dismissal of a false-marketing suit involving AstraZeneca's anti-psychotic drug Seroquel because it didn't meet the new, tougher pleading standard the Court laid down in Iqbal. Now we have word of two other recent Iqbal dismissals involving controversial products.
Two More 'Iqbal' Dismissals Emerge in Product Liability Cases
The American Lawyer
August 4, 2009